Barclays Keeps Their Sell Rating on DiaSorin S.p.A. (0GZX)

Barclays maintained a Sell rating on DiaSorin S.p.A. in a note released Sept. 7, with a €70.00 price target. The stock closed the prior Monday at €74.04. According to TipRanks, analyst Charles Pitman CFA is a 5-star rated forecaster with an average return of 16.0% and a 68.48% success rate. Wall Street consensus described in the report remains a Moderate Sell for DiaSorin, with a €68.00 average price target, implying an 8.16% downside versus current levels. UBS also kept a Sell rating on Aug. 24, targeting €55.00. For the quarter ended June 30, DiaSorin posted revenue of €602 million and net profit of €84 million, compared with €306.27 million revenue and €47.4 million net profit a year earlier.